Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MASP2 | O00187 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.61 |
| ▸ | MEN1 | O00255 | 4/20 | 0.61 |
| ▸ | DAPK3 | O43293 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | ERO1A | Q96HE7 | 1/20 | 0.56 |
| ▸ | PLCG2 | P16885 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.50 |
| ▸ | CRHBP | P24387 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6794620 | 1.00 | MASP2 (0.62) | MASP2KMT2AMEN1DAPK3ALDH1A1 | |
| SCHEMBL15421499 | 0.85 | KMT2A (0.81) | MASP2KMT2AMEN1DAPK3ALDH1A1 | |
| SCHEMBL6789979 | 0.85 | KMT2A (0.81) | MASP2KMT2AMEN1DAPK3ALDH1A1 | |
| SCHEMBL6789975 | 0.85 | KMT2A (0.81) | MASP2KMT2AMEN1DAPK3ALDH1A1 | |
| SCHEMBL13049353 | 0.85 | KMT2A (0.57) | MASP2KMT2AMEN1DAPK3ALDH1A1 | |
| SCHEMBL6795716 | 0.84 | MASP2 (0.67) | MASP2KMT2AMEN1ALDH1A1MAPT | |
| SCHEMBL6795718 | 0.84 | MASP2 (0.67) | MASP2KMT2AMEN1ALDH1A1MAPT | |
| SCHEMBL15689597 | 0.82 | MEN1 (0.57) | MASP2KMT2AMEN1DAPK3ALDH1A1 | |
| SCHEMBL4688693 | 0.82 | MEN1 (0.57) | MASP2KMT2AMEN1DAPK3ALDH1A1 | |
| SCHEMBL4688695 | 0.82 | MEN1 (0.57) | MASP2KMT2AMEN1DAPK3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040180943-A1 | Oxazolone analogs as amyloid aggregation inhibitors and for the treatment of alzheimer's disease and disorders related to amyloidosis | WARNER-LAMBERT COMPANY LLC | 2004-09-16 | — | — | US | claimed |
| US-20040180943-A1 | Oxazolone analogs as amyloid aggregation inhibitors and for the treatment of alzheimer's disease and disorders related to amyloidosis | WARNER-LAMBERT COMPANY LLC | 2004-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040180943-A1 | Oxazolone analogs as amyloid aggregation inhibitors and for the treatment of alzheimer's disease and disorders related to amyloidosis | APP, PSEN1, PSEN2 | MASP2 1759/4885KMT2A 4782/4885MEN1 2646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.